Please use this identifier to cite or link to this item:
|Title:||Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study|
Cunningham, Evan B.
et al, Various
Foster, Graham R
Nepean Clinical School: Medicine
|Publisher:||BioMed Central Ltd.|
|Citation:||Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study, BMC Infectious Diseases, vol.17, 1, 2017,pp 1-12|
|Department/Unit/Centre:||Nepean Clinical School: Medicine|
|Disclaimer:||This work has been made available to the staff and students of the University of Sydney for the purposes of research and study only. It constitutes material that is held by the University for the purposes of reporting for HERDC and the ERA. This work may not be downloaded, copied and distributed to any third party .|
|Type:||C1 - Refereed Journal articles|
|Appears in Collections:||University of Sydney Research Outputs|
Items in Sydney Research Online are protected by copyright, with all rights reserved, unless otherwise indicated.